Combination Chemotherapy and Rituximab in Treating Patients With Primary Mediastinal Diffuse Large B-Cell Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Peter Johnson, MD
University Hospital Southampton NHS Foundation Trust
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Leeds Cancer Centre at St. James'S University Hospital
Leeds, England, United Kingdom
Recruiting - St. George'S Hospital
London, England, United Kingdom
Recruiting - Christie Hospital
Manchester, England, United Kingdom
Recruiting - Mount Vernon Cancer Centre at Mount Vernon Hospital
Northwood, England, United Kingdom
Recruiting - Cancer Research Centre at Weston Park Hospital
Sheffield, England, United Kingdom
Recruiting - Southampton General Hospital
Southampton, England, United Kingdom
Recruiting - Royal Marsden - Surrey
Sutton, England, United Kingdom
Recruiting - Saint Bartholomew'S Hospital
London, United Kingdom
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2007
- Primary completion
- —
- Completion
- —
- Last update posted
- 8 Jul 2009
- Registered enrollment
- 120
- Registry id
- NCT00689845
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.